Kalm Health

What the service is

Kalm Health is an online telehealth provider offering at-home low-dose ketamine therapy prescribed by licensed providers and shipped nationwide. The service is licensed and available in all 50 states, treating anxiety, depression, stress, PTSD, insomnia and OCD. Kalm reports treating over 50,847 patients and claims the status of being the only provider licensed and available in all 50 states, with pricing starting at $124 per month. The service works with affiliated psychiatric medical practices that are independently owned and operated, so while Kalm serves as the platform connecting patients to care, the prescribing clinicians are independent practitioners.

How treatment works

To start Kalm treatment, you complete a quick self-assessment to see if you pre-qualify for the program. This allows you to sign up and schedule a consultation with a licensed provider who will determine whether you are a good fit for ketamine therapy and design your personalized treatment plan. After approval by the licensed provider, your customized ketamine prescription ships discreetly to your home with free shipping anywhere in the United States. Kalm emphasizes that there are no pharmacy trips or waiting rooms; treatment arrives at your door.

Once you receive your medication, you take it at home as prescribed without interrupting your daily activities. Kalm's low-dose protocol does not require downtime, trip sitters to supervise you, or special conditions. You can continue your normal routine while undergoing treatment. The medication is compatible with most antidepressants, so if you are already taking an SSRI or other antidepressant medication, you can typically continue that treatment alongside ketamine. Your provider will review your full medication list during your consultation to screen for any interactions.

After starting treatment, you have ongoing support built into your subscription. Kalm includes unlimited check-ins with your doctor whenever you need them, which distinguishes it from services requiring pre-scheduled appointments only. You also receive seven-day messaging support from the care team, providing access to help outside typical office hours. The company emphasizes that you are never on your own during your treatment journey.

The clinical basis for Kalm's approach is that ketamine promotes neuroplasticity, creating new neural pathways that heal negative thought patterns, foster self-compassion and reduce reactive triggers. The site states that 91% of Kalm patients experience symptom relief within their first five days of treatment, with many reporting improvements after their very first dose. Kalm uses a proprietary low-dose ketamine protocol and positions itself as the most affordable at-home ketamine option, guaranteeing the lowest price with a promise to beat any competitor price by 20%.

What you pay and who covers it

Kalm's pricing is simple and transparent: $124 per month with no long-term commitment. Your personalized prescription is customized to you, and the company guarantees the lowest price, promising to beat any lower price you find by 20%. The monthly subscription includes one month's supply of medication prescribed and customized to you, doctor consultation and prescription included, unlimited check-ins with your doctor and free shipping directly to you anywhere in the United States.

Ketamine therapy is rarely covered by traditional insurance, according to Kalm's site. The company notes that it works outside insurance constraints to provide what it describes as cutting-edge protocols in convenient telehealth settings. However, Kalm accepts HSA (Health Savings Account) and FSA (Flexible Spending Account) funds, allowing you to submit for reimbursement if you maintain those accounts through your employer or independently. This creates a potential path to offset costs if you have those account types available.

The company guarantees that if you find a lower price for comparable ketamine therapy elsewhere, they will beat it by 20%, making price comparison possible before committing. This pricing transparency contrasts with many ketamine providers that require a consultation before revealing costs. Kalm's affordable entry point at $124 per month is positioned as more accessible than traditional high-dose ketamine clinics, which can run several hundred to several thousand dollars monthly.

What the service does not say

Kalm does not publish detailed breakdowns of treatment outcomes by condition. While the site states that 91% of patients experience symptom relief within their first five days, it does not clarify whether that applies equally to anxiety, depression, PTSD and insomnia, or whether relief rates vary. The site does not recommend a typical treatment duration or explain whether most patients stay on ketamine short-term or long-term. It mentions that the low-dose protocol has been used safely long-term but does not detail long-term outcome data or what happens after you stop treatment.

The company does not transparently discuss medical contraindications or which patient populations should not pursue treatment. While the provider consultation screens for interactions with antidepressants, the main site does not list specific medical conditions, medications or histories that would disqualify someone. It does not specify the provider approval rate, typical timeline from consultation to receiving your first prescription, or expected wait times. Kalm does not clarify how the seven-day messaging support works outside typical business hours or the escalation process for urgent mental health crises.

The site does not detail provider credentials beyond describing them as licensed, nor does it clarify whether prescribers are psychiatrists, psychiatric nurse practitioners, or other licensed medical providers. No case studies, clinical research or efficacy studies specific to Kalm's protocol are published on the main page. The site does not explain what happens if the dose needs major adjustments or if side effects occur, or how those situations are managed in an at-home setting without in-person evaluation capacity.

Who it fits

Kalm is ideal for patients with anxiety, depression, stress, PTSD or insomnia who want low-cost, accessible at-home ketamine therapy without intensive clinical infrastructure. It suits anyone in any of the 50 states, making it the most geographically accessible option in this category. The $124 per month pricing makes it affordable for patients paying out-of-pocket and for those with HSA or FSA accounts seeking to minimize costs. Patients already on antidepressants who want to add ketamine can do so without interrupting their current medication. The company's emphasis on unlimited check-ins and messaging support appeals to those who want accessible provider contact without being charged per interaction.

Kalm is not ideal for patients who need or prefer in-person medical evaluation and oversight, particularly those with complex medical histories requiring intensive review. It is not suitable for those seeking high-dose psychedelic ketamine experiences or classical ketamine-assisted psychotherapy paired with dedicated therapy sessions; Kalm's protocol is low-dose and medication-focused rather than therapy-paired. Patients in acute crisis who need immediate in-person evaluation should pursue emergency services instead. Those who want therapist-guided ketamine integration or psychedelic preparation and processing are better served by office-based programs like Journey Clinical that combine medication with licensed therapy. Patients whose insurance covers different forms of ketamine treatment through traditional channels might find insurance-covered options with lower total out-of-pocket costs than Kalm's self-pay model.